MAPT and Alzheimer disease: Functional enrichment analysis showed that the 100 CSF markers dysregulated in preclinical AD were mainly associated to proteolysis and immune response (Supplementary Material: Fig. 2), pathways involved in AD pathophysiology associated with the development of amyloid and tau misfolding [1, 2].